Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran

Background/Aims: Ardabil Province, in northwestern Iran, has the highest rate of gastric (predominantly cardia) adenocarcinoma in Iran. This study aimed to investigate the feasibility of endoscopic screening and to look for associated Helicobacter pylori infection and gastric precancerous lesions. Methods: One thousand one hundred and five adult volunteers, residents of Ardabil and Meshkinshahr, districts, 40 years old and above were selected and invited by a simple random household canvass in rural and urban locations. Informed consents were obtained and upper gastrointestinal video endoscopy was performed to biopsy all visible lesions and standard sites in the antrum, corpus, and cardia Results: One thousand and eleven of the invited individuals agreed to participate, including 494 men and 517 women, with a mean (SD) age of 53.32 (10.39) years. Endoscopy was well tolerated by all subjects; 96.7% of antral and 80.7% of cardia mucosal biopsies were satisfactory. The urease test or histology for H pylori was positive in at least 89.2% of subjects. Histological evidence of mucosal atrophy was seen in 39.3% of antral and 21.9% of cardia samples. Chronic gastritis with or without activity, reactive atypia of glandular epithelium, intestinal metaplasia, dysplasia, and cancer were found in 95.1%, 38.0%, 8.7%, 0.2%, and 0.3% of antral and 85.3%, 22.9%, 3.8%, 0.3%, and 0.1% of cardiac biopsies, respectively. Conclusion: Endoscopic screening for upper gastrointestinal diseases was feasible and well tolerated in Ardabil, Iran. Most subjects showed H pylori infection. Atrophic gastritis, reactive atypia, and intestinal metaplasia were common in antrum, corpus, and cardia subsites.

[1]  R. Malekzadeh,et al.  Cancer occurrence in Ardabil: Results of a population‐based Cancer Registry from Iran , 2003, International journal of cancer.

[2]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[3]  K. McColl,et al.  Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction. , 2002, Gastroenterology.

[4]  C. Mowat,et al.  In vitro Studies Indicate that Acid Catalysed Generation of N-Nitrosocompounds from Dietary Nitrate Will be Maximal at the Gastro-oesophageal Junction and Cardia , 2002, Scandinavian journal of gastroenterology.

[5]  C. Wallerstein Costa Rica tackles high rates of stomach cancer , 2001, BMJ : British Medical Journal.

[6]  R. P. Blankfield,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[7]  M. Gail,et al.  Re: Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2001, Journal of the National Cancer Institute.

[8]  M. Blaser,et al.  Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. , 2001, Journal of the National Cancer Institute.

[9]  M F Dixon,et al.  The Vienna classification of gastrointestinal epithelial neoplasia , 2000, Gut.

[10]  M. Gail,et al.  Evolution of precancerous lesions in a rural Chinese population at high risk of gastric cancer , 1999, International journal of cancer.

[11]  H. Nagai,et al.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.

[12]  A B West,et al.  An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. , 1998, Cancer research.

[13]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1997 .

[14]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  D. Beall Classification and Grading of Gastritis: The Updated Sydney System , 1997 .

[16]  J. Gisbert,et al.  Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori. , 1997, Scandinavian journal of gastroenterology.

[17]  M F Dixon,et al.  Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.

[18]  Douglas K Owens,et al.  Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials , 1996, The Lancet.

[19]  M. Plummer,et al.  Determinants of plasma anti‐oxidant vitamin levels in a population at high risk for stomach cancer , 1996, International journal of cancer.

[20]  L. Engstrand,et al.  Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. , 1995, Gastroenterology.

[21]  S. Kikuchi,et al.  Serum anti‐Helicobacter pylori antibody and gastric carcinoma among young adults , 1995 .

[22]  W. Blot,et al.  Precancerous gastric lesions in a population at high risk of stomach cancer. , 1993, Cancer research.

[23]  P. Correa,et al.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. , 1992, Cancer research.

[24]  J. Fraumeni,et al.  Comparison of the Anatomic Distribution of Stomach Cancer and Precancerous Gastric Lesions , 1992, Japanese journal of cancer research : Gann.

[25]  E. Fontham,et al.  Gastric precancerous process in a high risk population: cross-sectional studies. , 1990, Cancer research.

[26]  A. Clouston TIMELY TOPIC: PREMALIGNANT LESIONS ASSOCIATED WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL TRACT , 2001, Pathology.

[27]  M. Gail,et al.  Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti-helicobacter pylori therapy. , 2000, Journal of the National Cancer Institute.

[28]  R. Malekzadeh,et al.  GASTRIC CARDIA CANCER; THE MOST COMMON TYPE OF UPPER GASTROINTESTINAL CANCER IN ARDABIL, IRAN: AN ENDOSCOPY CLINIC EXPERIENCE , 2000 .

[29]  J. Mikaeili,et al.  PREVALENCE OF HELICOBACTER PYLORI IN TWO IRANIAN PROVINCES WITH HIGH AND LOW INCIDENCE OF GASTRIC CARCINOMA , 2000 .

[30]  S. Vollset,et al.  Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. , 1999, Scandinavian journal of gastroenterology.

[31]  O. Kobayashi,et al.  Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. , 1995, Cancer.

[32]  D. Forman,et al.  H. pylori and gastric cancer: the significance of the problem , 1994 .